Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Wittebole

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Kidney International Reports|November 20, 2018
Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) StudyAlexa Hollinger, Xavier Wittebole, Bruno François, et al.
Intensive Care Medicine|October 4, 2021
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre-François Laterre, Peter Pickkers, Gernot Marx, et al.
JAMA|May 20, 2019
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical TrialJean-Louis Vincent, Bruno Francois, Igor Zabolotskikh, et al.
Critical Care (London, England)|December 26, 2018
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) studyAlexandre Mebazaa, Christopher Geven, Alexa Hollinger, et al.
Critical Care (London, England)|February 16, 2021
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational studyAlice Blet, Benjamin Deniau, Karine Santos, et al.
The New England Journal of Medicine|May 19, 2015
High-flow oxygen through nasal cannula in acute hypoxemic respiratory failureJean-Pierre Frat, Arnaud W Thille, Alain Mercat, et al.
JAMA|March 21, 2013
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trialSteven M Opal, Pierre-Francois Laterre, Bruno Francois, et al.
JAMA|October 3, 2019
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical TrialPierre-Francois Laterre, Scott M Berry, Allan Blemings, et al.
The Lancet. Respiratory Medicine|November 10, 2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trialJozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2020
The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy StudyJason A Roberts, Gavin M Joynt, Anna Lee, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Kidney International Reports|November 20, 2018
Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) StudyAlexa Hollinger, Xavier Wittebole, Bruno François, et al.
Intensive Care Medicine|October 4, 2021
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre-François Laterre, Peter Pickkers, Gernot Marx, et al.
JAMA|May 20, 2019
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical TrialJean-Louis Vincent, Bruno Francois, Igor Zabolotskikh, et al.
Critical Care (London, England)|December 26, 2018
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) studyAlexandre Mebazaa, Christopher Geven, Alexa Hollinger, et al.
Critical Care (London, England)|February 16, 2021
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational studyAlice Blet, Benjamin Deniau, Karine Santos, et al.
The New England Journal of Medicine|May 19, 2015
High-flow oxygen through nasal cannula in acute hypoxemic respiratory failureJean-Pierre Frat, Arnaud W Thille, Alain Mercat, et al.
JAMA|March 21, 2013
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trialSteven M Opal, Pierre-Francois Laterre, Bruno Francois, et al.
JAMA|October 3, 2019
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical TrialPierre-Francois Laterre, Scott M Berry, Allan Blemings, et al.
The Lancet. Respiratory Medicine|November 10, 2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trialJozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2020
The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy StudyJason A Roberts, Gavin M Joynt, Anna Lee, et al.
Pageof 12